These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2604293)

  • 41. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.
    Levy E; Gurbindo C; Lacaille F; Paradis K; Thibault L; Seidman E
    Pediatr Res; 1993 Aug; 34(2):162-6. PubMed ID: 8233719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tumor necrosis factor in the serum--a useful supplemental parameter in the diagnosis of infection in cystic fibrosis?].
    Heininger U; Böwing B; Forster D; Berthold M
    Klin Padiatr; 1991; 203(3):158-61. PubMed ID: 1857050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis.
    Husson MO; Wizla-Derambure N; Turck D; Gosset P; Wallaert B
    J Antimicrob Chemother; 2005 Jul; 56(1):247-9. PubMed ID: 15932936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor-alpha in malignant disease.
    Abrahamsson J; Carlsson B; Mellander L
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):364-9. PubMed ID: 8214357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
    Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
    J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients.
    Salva PS; Doyle NA; Graham L; Eigen H; Doerschuk CM
    Pediatr Pulmonol; 1996 Jan; 21(1):11-9. PubMed ID: 8776260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.
    Freedman SD; Weinstein D; Blanco PG; Martinez-Clark P; Urman S; Zaman M; Morrow JD; Alvarez JG
    J Appl Physiol (1985); 2002 May; 92(5):2169-76. PubMed ID: 11960971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis.
    Elborn JS; Cordon SM; Western PJ; Macdonald IA; Shale DJ
    Clin Sci (Lond); 1993 Nov; 85(5):563-8. PubMed ID: 8287644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis.
    Briars GL; Dean TP; Murphy JL; Rolles CJ; Warner JO
    Arch Dis Child; 1995 Jul; 73(1):74-6. PubMed ID: 7639556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.
    Calandra T; Baumgartner JD; Grau GE; Wu MM; Lambert PH; Schellekens J; Verhoef J; Glauser MP
    J Infect Dis; 1990 May; 161(5):982-7. PubMed ID: 2109023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of lung disease in cystic fibrosis.
    Dinwiddie R
    Respiration; 2000; 67(1):3-8. PubMed ID: 10705255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.
    Moore JE; Shaw A; Millar BC; Martin SL; Murphy PG; Downey DG; Ennis M; Elborn JS
    Br J Biomed Sci; 2004; 61(3):146-7. PubMed ID: 15462261
    [No Abstract]   [Full Text] [Related]  

  • 54. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha.
    Banks RE; Evans SW; Alexander D; McMahon MJ; Whicher JT
    Cytokine; 1991 Jan; 3(1):12-6. PubMed ID: 1883952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On tumor necrosis factor alpha in CF.
    Elborn JS; Nixon L; Bell SC; Shale DJ
    Pediatr Pulmonol; 1994 Jun; 17(6):411-2. PubMed ID: 7993482
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of the effect of candidate anti-inflammatory treatments on the interaction between meningococci and inflammatory cells in vitro in a whole blood model.
    Chan B; Kalabalikis P; Klein N; Heyderman R; Levin M
    Biotherapy; 1996; 9(4):221-8. PubMed ID: 9012541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of proteinase inhibitors in human serum].
    Bondarenko AN
    Klin Lab Diagn; 2004 May; (5):11-5. PubMed ID: 15230109
    [No Abstract]   [Full Text] [Related]  

  • 58. Cystic fibrosis: current concepts.
    Polley MJ; Bearn AG
    J Med Genet; 1974 Sep; 11(3):249-52. PubMed ID: 4139260
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased production of TNF-alpha may play a role in osteoporosis in cystic fibrosis patients.
    Teramoto S; Matsuse T; Ouchi Y
    Chest; 1997 Aug; 112(2):574. PubMed ID: 9266915
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Complement components in cystic fibrosis.
    Conover JH; Conod EJ; Hirschhorn K
    Lancet; 1973 Dec; 2(7844):1501. PubMed ID: 4129344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.